Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia

NCT04796064 | Completed

• 1 other identifier: Sarcopenia
• Study Type: interventional
• Target: 76
• Locations: 1 country
• Sites: 1

Brief Summary

Sarcopenia is the major health concern and common consequence of COVID-19 in the ageing population. The objective of this study is to find and compare low and high-intensity aerobic training protocols on clinical and psychological effects in community-dwelling older men with post-COVID 19 Sarcopenia.

Conditions

Sarcopenia

Outcome Measures

Primary Outcomes (1)

• Handgrip strength

  It is a simple and cost-effective test to measure the upper limb strength

  8 weeks

Study Arms (2)

low-intensity aerobic training group

EXPERIMENTAL

Other: low-intensity aerobic training

high-intensity aerobic training group

EXPERIMENTAL

Other: low-intensity aerobic training

Interventions

low-intensity aerobic training OTHER

A low-intensity aerobic training group started with 15 minutes of warm-up, which includes static stretching of the upper and lower limb muscles. then participants were instructed to do 30 minutes of low-intensity aerobic training exercises, which include 20 minutes on the treadmill and 10 minutes of cycle ergometer, followed by 10 minutes of cool down. \- In high-intensity training (HAT) the same protocol has been followed, but the intensity of exercises was fixed between 60% to 80 % of maximum heart rate. The strength training includes major group muscles such as shoulder flexors, extensors, and abductors, elbow flexors and extensors, hip flexors\& extensors, knee flexors\&extensors, abdominal and back muscles also were trained. Each group of muscles was trained for 10 repetitions for 3 sets with a rest period of 5 minutes.

high-intensity aerobic training group; low-intensity aerobic training group

Eligibility Criteria

• Age: 60 Years - 80 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age range of 60 - 80 years with
• A positive diagnosis of post-COVID-19 sarcopenia

You may not qualify if:

• Under medication
• History of lower limb surgeries, fractures
• Cardiac problems
• Respiratory problems
• Neurological problems
• Systemic problems and any other contraindications for aerobic training

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Marwa Eid

Cairo, 2011, Egypt

Location

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular Atrophy; Neuromuscular Manifestations; Neurologic Manifestations; Nervous System Diseases; Atrophy; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms; Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: assistant professor of physical therapy for surgery

Study Record Dates

• First Submitted: March 10, 2021
• First Posted: March 12, 2021
• Study Start: March 30, 2020
• Primary Completion: November 5, 2020
• Study Completion: December 15, 2020
• Last Updated: March 12, 2021

Record last verified: 2021-03

Locations

EG (1)